Yang, M.; Ji, S.; Xu, L.; Zhang, Q.; Li, Y.; Gao, H.; Bu, B.
The Clinicopathological Distinction between Immune-Mediated Necrotizing Myopathy and Limb–Girdle Muscular Dystrophy R2: Key Points to Prevent Misdiagnosis. J. Clin. Med. 2022, 11, 6566.
https://doi.org/10.3390/jcm11216566
AMA Style
Yang M, Ji S, Xu L, Zhang Q, Li Y, Gao H, Bu B.
The Clinicopathological Distinction between Immune-Mediated Necrotizing Myopathy and Limb–Girdle Muscular Dystrophy R2: Key Points to Prevent Misdiagnosis. Journal of Clinical Medicine. 2022; 11(21):6566.
https://doi.org/10.3390/jcm11216566
Chicago/Turabian Style
Yang, Mengge, Suqiong Ji, Li Xu, Qing Zhang, Yue Li, Huajie Gao, and Bitao Bu.
2022. "The Clinicopathological Distinction between Immune-Mediated Necrotizing Myopathy and Limb–Girdle Muscular Dystrophy R2: Key Points to Prevent Misdiagnosis" Journal of Clinical Medicine 11, no. 21: 6566.
https://doi.org/10.3390/jcm11216566
APA Style
Yang, M., Ji, S., Xu, L., Zhang, Q., Li, Y., Gao, H., & Bu, B.
(2022). The Clinicopathological Distinction between Immune-Mediated Necrotizing Myopathy and Limb–Girdle Muscular Dystrophy R2: Key Points to Prevent Misdiagnosis. Journal of Clinical Medicine, 11(21), 6566.
https://doi.org/10.3390/jcm11216566